Journal of Pancreatology (Dec 2023)
Chinese expert consensus on multidisciplinary diagnosis and treatment of pancreatic neuroendocrine liver metastases
- Yihebali Chi,
- Liming Jiang,
- Susheng Shi,
- Shun He,
- Chunmei Bai,
- Dan Cao,
- Jianqiang Cai,
- Qichen Chen,
- Xiao Chen,
- Yiqiao Deng,
- Shunda Du,
- Zhen Huang,
- Li Huo,
- Yuan Ji,
- Jie Li,
- Wenhui Lou,
- Jie Luo,
- Xueying Shi,
- Lijie Song,
- Bei Sun,
- Huangying Tan,
- Feng Wang,
- Xuan Wang,
- Zhewen Wei,
- Wenming Wu,
- Dianrong Xiu,
- Jianming Xu,
- Huadan Xue,
- Yi Yang,
- Fei Yin,
- Jiangyuan Yu,
- Chunhui Yuan,
- Yefan Zhang,
- Weixun Zhou,
- Dongbing Zhao,
- Hong Zhao
Affiliations
- Yihebali Chi
- a Department of Medical Oncology, National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Liming Jiang
- b Department of Diagnostic Radiology, National Cancer Center Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Susheng Shi
- c Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Shun He
- d Department of Endoscopy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Chunmei Bai
- e Department of Medical Oncology, Peking Union Medical College Hospital, Beijing, China
- Dan Cao
- f Department of Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China
- Jianqiang Cai
- g Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Qichen Chen
- g Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Xiao Chen
- g Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Yiqiao Deng
- g Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Shunda Du
- h Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Zhen Huang
- g Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Li Huo
- i Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Yuan Ji
- j Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China
- Jie Li
- k Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China
- Wenhui Lou
- l Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
- Jie Luo
- m Department of Pathology, China-Japan Friendship Hospital, Beijing, China
- Xueying Shi
- n Department of Pathology, Peking University Third Hospital, School of Basic Medical Science, Peking University Health Science Center, Beijing, China
- Lijie Song
- o Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Bei Sun
- p Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China
- Huangying Tan
- q Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China
- Feng Wang
- r Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
- Xuan Wang
- s Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Zhewen Wei
- g Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Wenming Wu
- t Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Dianrong Xiu
- u Department of General Surgery, Peking University Third Hospital, Beijing, China
- Jianming Xu
- v Department of Gastrointestinal Oncology, The Fifth Medical Center of the PLA General Hospital, Beijing, China
- Huadan Xue
- s Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Yi Yang
- g Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Fei Yin
- w Department of Gastroenterology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China
- Jiangyuan Yu
- x Department of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University Cancer Hospital & Institute, Beijing, China
- Chunhui Yuan
- u Department of General Surgery, Peking University Third Hospital, Beijing, China
- Yefan Zhang
- g Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Weixun Zhou
- y Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Dongbing Zhao
- z Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Hong Zhao
- g Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- DOI
- https://doi.org/10.1097/JP9.0000000000000141
- Journal volume & issue
-
Vol. 6,
no. 4
pp. 139 – 150
Abstract
Many management strategies are available for pancreatic neuroendocrine neoplasms with liver metastases. However, a lack of biological, molecular, and genomic information and an absence of data from rigorous trials limit the validity of these strategies. This review presents the viewpoints from an international conference consisting of several expert working groups. The working groups reviewed a series of questions of particular interest to clinicians taking care of patients with pancreatic neuroendocrine neoplasms with liver metastases by reviewing the existing management strategies and literature, evaluating the evidence on which management decisions were based, developing internationally acceptable recommendations for clinical practice, and making recommendations for clinical and research endeavors. The review for each question will be followed by recommendations from the panel.
